Member Info for Woodwood

Have to admit this AIX move is still really odd. And the only other business I know off that did something similar, Polymetal the once FTSE100 esteemed mining company, delisted completely and moved to the AIX. This was in order to be able to sell their Russain assets and as far as I can tell it's all pretty shady what is happening the AIX re Solidcare Resources as it is now named. Most UK residents had to just sell up anyway as there are no brokers for the AIX for UK residents.

This disconnect from UK and trading on the AIX is the thing that made me think the currency shift was relevant, but you do start to feel either completely out of your comfort zone/knowledge around all of this, or just being BS'd!

Yeh young pharma or similarly something like mining stocks on AIM you got to be in it for significant company events. Buy out mergers miracles whatever...my thought is if you're watching the share price of Faron and riding with it daily, weekly that's got to be bad for your health lol if you're with it just maintain your position, take up offers avoid dilution etc and don't sunken cost yourself.

Nice to enjoy this news and little rise, cracking for those patients. If this disease ever comes near anyone you know, who you gonna call?👻🔫

5 hours AIX has been open and nothing.

Am I really just living the sunken fallacy life with this now.

Absolutely this is a time for this board to be pretty negative, to put it mildly.

This was the only thing I could think optimistically was happening. Trades so large that the market maker tranches they took from AIM weren't big enough and there are some fairly chunky trades here this morning. But really not quite what I thought I'd be waking up to this morning...just something?!?!

Just to add. Most you guys posting here are insane, straight up out of wolf of wall street levels lol can't keep up with the chaos

..as someone unfamiliar with lots of the elements of company stock trading. This share was part of my excited gambling entry to stocks and it quite effectively turned me into a more passive slow burn don't get too involved kinda guy.

But I still have my shares here and just have enjoyed kinda watching it play out.

The dual listing can someone give me a Feynman explanation how this is helpful. I watched polymetal move completely to the AIX and it was disastrous probably, shares gone and no way for UK residents to trade them. With a dual listing, I think it leaves the UK market open to receiving dividends and trading etc but how does it actually help on the ground with getting a sale done if the UK listing and regulations were an issue in the first place??

I think I've just missed Marku, did anyone catch it?

Ok appreciate the enthusiasm but what does the confirmation statement have to do with any ducks in rows. It is simply a required annual filing and quite often one of the most boring company documents. Following this board and waiting for company updates is made insane by this bs.

New to AIM stocks really, faron I've been following since about 2 years ago now but was the only one. Price moves make no sense on here, I'd love to spend a day as a fly on the wall with mm's...

When you look again at all the areas this company is innovating in, these guys should be shouting from the rooftops. Hopefully the presentation upcoming is bringing test results, looking forward to seeing what has been achieved. I must admit the quiet demeanor of Marku was something I valued but sometimes I want him to just kick some ass (WHO) and tell the world.

Appreciate that there is considered reflection here (unlike some of the mental threads on eua!) and a company that is concerned with good science and truth. But anyone got any ideas - SNG rise must be interferon but diddly move here, let's have some buzz farn! Doing great work but all quiet

Great news tbh. Amazing how poor the WHO was to have failed with interferon treatments...jeez

Reading around is there anywhere stating when more data is expected from clevegen? This is the matins trial correct...where the September presentation had only previously released data ?

Q amazing...to see the share price change so much for basically no reason. Painful for sure...but something of a gift if you see the value in this company and the good science they are doing.

Gkb interesting point as at what stage does the company have to take some responsibility in ensuring their treatments are used properly or atleast used(!) and then getting out/withdrawing if not. I have no idea how plausable withdrawing is in reality, but reputationally clearly the damage is huge and ultimately means poor treatment for patients...

Time to start ignoring this forum for a bit probably, getting a bit personal.. hold for actual news

I wouldn't say that so definitively, looking back at the RNS from 2feb this year what has just occurred in the who study beggars belief...
Company notes with interest a recent recommendation by the World Health Organization (WHO) that steroids should not be used on coronavirus infected patients1. One of the main first lines of defence against viral infection is endogenous IFN-beta production2. Blocking endogenous IFN-beta production using steroids may be deleterious to treatment outcomes in these patients. Therefore, exogenous IFN-beta (like Traumakine) can strengthen further this endogenous IFN-beta action and provide maximal protection against viral infections but it has to be administered without concomitant corticosteroids, which have the capacity to disturb or block IFN-beta action.



A recent descriptive study published in The Lancet3 on the 2019 novel coronavirus (2019-nCoV) outbreak in Wuhan, China reports that 17% of the 99 patients with 2019-nCoV pneumonia developed Acute Respiratory Distress Syndrome ("ARDS") and 11% worsened in a short period of time and died of multiple organ failure. 19% of patients in the study received corticosteroids, a treatment option no longer recommended by the WHO.



Dr. Markku Jalkanen, Faron's CEO, said: "With no currently approved pharmacological treatments available, ARDS remains a significant problem for patients and healthcare systems. We are pleased to note that the WHO has recognised the risk of using corticosteroids on patients with coronavirus, which aligns with our findings from post-hoc analysis of the INTEREST study.



"One of the main first lines of defence against viral infection is endogenous interferon-beta production. Faron believes Traumakine treatment, in the absence of concomitant corticosteroid use, can further strengthen this endogenous IFN-beta action and provide increased protection against serious lung complications arising from viral infections. Faron remains committed to developing Traumakine for the potentially fatal condition ARDS."